Dexlansoprazole 30mg Delayed-release Capsules

Dexlansoprazole 30mg is a dual delayed-release proton pump inhibitor used for reflux-related heartburn and erosive oesophagitis. Its two granule populations release medicine at different stages of intestinal transit, supporting acid control over an extended period. Dexlansoprazole and lansoprazole are distinct active ingredients, not alternative spellings of the same API.
Swallow the delayed-release capsule whole with water once daily, with or without food. Keep a consistent daily time. Do not crush or chew the capsule contents, because the granule coatings control release. A change from another PPI requires selection of an appropriate regimen rather than a milligram-for-milligram substitution.
Dexlansoprazole blocks H+/K+-ATPase proton pumps in stomach parietal cells. The dual delayed-release system produces two periods of drug release while the active ingredient suppresses acid secretion.
Diarrhoea, abdominal pain, nausea, wind and headache can occur. Persistent watery diarrhoea, reduced urine output, severe rash, or muscle cramps with an abnormal heartbeat needs assessment.
Tell your doctor about liver disease, low magnesium, vitamin B12 deficiency, osteoporosis, pregnancy and breastfeeding. Rilpivirine and some other medicines requiring stomach acid for absorption can interact, as can high-dose methotrexate. Trouble swallowing, unexplained weight loss or gastrointestinal bleeding should not be treated as ordinary reflux.
Longer acid suppression can reduce daytime or night-time reflux discomfort and support healing of the oesophageal lining. Meal-independent administration offers flexibility compared with PPIs whose effect depends more on pre-meal timing.
It contains granules that release at different pH levels, giving two release phases. This differs from simply using a higher dose of an ordinary immediate-release medicine.
Dexlansoprazole can be taken without regard to meals. This instruction is formulation-specific and should not be transferred automatically to lansoprazole or other PPIs.
The 60mg strength is commonly used during healing of erosive oesophagitis, while 30mg is commonly used for maintenance or symptomatic non-erosive GERD. The diagnosis and treatment phase determine the regimen.
An extra PPI capsule is not a rapid rescue antacid. Frequent breakthrough symptoms need assessment of timing, adherence and the diagnosis rather than repeated unscheduled doses.
Dual delayed release: release from two granule populations at different stages. Erosive oesophagitis: acid-related injury to the oesophageal lining. Maintenance therapy: treatment used to preserve a response after initial healing. Parietal cell: a stomach cell that produces acid; AR: Dexlansoprazole 30mg كبسولات متأخرة التحرر; FR: Dexlansoprazole 30mg gélules à libération retardée; PT: Dexlansoprazole 30mg cápsulas de libertação retardada; ES: Dexlansoprazole 30mg cápsulas de liberación retardada; RU: Dexlansoprazole 30mg капсулы с отсроченным высвобождением; ID: Dexlansoprazole 30mg kapsul lepas tunda; VI: Dexlansoprazole 30mg viên nang giải phóng chậm; MS: Dexlansoprazole 30mg kapsul pelepasan tertunda; TL: Dexlansoprazole 30mg kapsulang may naantalang paglabas; ZH-SG: Dexlansoprazole 30mg 迟释胶囊
International B2B Enquiry
Send a structured B2B enquiry for Dexlansoprazole 30mg Delayed-release Capsules under Digestive Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Dexlansoprazole 30mg Delayed-release Capsules